The Journal of the National Comprehensive Cancer Network (JNCCN) has named Dr. Harold J. Burstein as its new editor-in-chief. JNCCN is a peer-reviewed, indexed medical journal providing the latest information about optimal clinical practices, oncology outcomes, and new research initiatives.
Dr. Burstein is a medical oncologist specialising in the treatment of breast cancer at the Dana-Farber Cancer Institute in Boston and an Associate Professor of Medicine at Harvard Medical School. Also, he serves as member of several national committees, including the NCCN Breast Cancer Guidelines Panel. In his new position, Dr. Burstein will lead and set the direction of the journal as well as serve as the ambassador for JNCCN in the oncology community.
JNCCN is a controlled circulation publication distributed to more than 20,000 oncologic subspecialists, including medical and radiation oncologists, hematologists, oncologic surgeons, advanced practice nurses, etc. It is currently ranked seventh in readership among the top oncology publications, according to FOCUS, a leading readership-measurement company for medical journals.
